Epidemiological data on systemic lupus erythematosus in native sub-Saharan Africans

Data Brief. 2019 Nov 27:28:104909. doi: 10.1016/j.dib.2019.104909. eCollection 2020 Feb.

Abstract

Multiethnic studies conducted outside sub-Saharan Africa identify African Black people as the highest-risk group for morbidity and mortality among the 5,000,000 people who are affected by lupus globally. In the meantime, there have bee few attempts to summarize lupus data from sub-Saharan africa. We therefore conducted a systematic review and meta-analysis addressing systemic lupus erythematosus in Native sub-Saharan Africans. This paper both serves as repository for and describes the data obtained by qualitative and quantitative synthesis, notably the pooled prevalence of autoantibodies, the pooled frequency of cumulative drug use, the prevalence of comorbidities/complications and the mortality rate in Native sub-Saharan Africans with systemic lupus erythematosus. These data are interpreted in the research article titled "Systemic lupus erythematosus in Native sub-Saharan Africans: a systematic review and meta-analysis" (Essouma et al., 2019) [1].

Keywords: Autoantibodies; Native sub-Saharan Africans; Outcomes; Systemic lupus erythematosus; Treatments.